Cargando…

Repeated B-cell depletion with rituximab in rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Edwards, J, Leandro, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833924/ http://dx.doi.org/10.1186/ar934

Ejemplares similares

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

The effect of B-cell depletion with an anti-CD20 antibody on the immunoglobulin heavy-chain repertoire in a patient with rheumatoid arthritis
por: Rouzière, A-S, et al.
Publicado: (2005)

B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide
por: Thiel, Jens, et al.
Publicado: (2011)

Effect of B cell depletion using peptide tetramers in collagen-induced arthritis
por: Michishita, Kazuya, et al.
Publicado: (2012)

Expression of 9G4 idiotope on autoantibodies to citrullinated peptides in patients with early inflammatory arthritis and established rheumatoid arthritis
por: Moura, Rita A, et al.
Publicado: (2012)

Impaired early B-cell tolerance in patients with rheumatoid arthritis
por: Samuels, J, et al.
Publicado: (2005)

Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis
por: Hsue, Priscilla Y., et al.
Publicado: (2014)

OA20 Combining B cell depletion and JAKi for difficult-to-treat rheumatoid arthritis
por: Lee, Sook Yan, et al.
Publicado: (2023)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

Cytokine pattern in very early rheumatoid arthritis favours B cell activation and survival
por: Moura, R A, et al.
Publicado: (2010)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Within-subject foot motion variability in patients with Rheumatoid Arthritis
por: Hooper, Lindsey, et al.
Publicado: (2010)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

The effect of Rituximab treatment on T cells
por: Diaz-Torné, C, et al.
Publicado: (2010)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Tuscano, Joseph M, et al.
Publicado: (2009)

Significance of fatigue in patients with rheumatoid arthritis
por: Singh, G, et al.
Publicado: (2003)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

Class switched memory B cells are enriched in the synovium after rituximab treatment
por: Möller, Burkhard, et al.
Publicado: (2007)

IL-17-producing (©)™T cells are important for the development of arthritis in a rheumatoid arthritis model
por: Akitsu, Aoi, et al.
Publicado: (2012)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

P26 A case of B-cell lymphoma affecting the eye in a patient with rheumatoid arthritis following a reduction in the frequency of rituximab therapy
por: Lau, Yen Zi, et al.
Publicado: (2021)

Citrullinated peptide-specific CD19(+ )B cells are present in synovial tissue and peripheral blood of patients with rheumatoid arthritis
por: Ruzickova, S, et al.
Publicado: (2005)

Inducible Treg cell populations as cell based-therapy for rheumatoid arthritis
por: Martire, Delphine, et al.
Publicado: (2012)

P02.48. Overcoming ego depletion: the effects of an optimism manipulation on repeated acts of self-control
por: Meevissen, Y, et al.
Publicado: (2012)

Genotype-dependent NOS-3 expression and rheumatoid arthritis
por: Cattaruzza, M, et al.
Publicado: (2005)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Clusterin, a potential pathophysiological actor in rheumatoid arthritis
por: Devauchelle, V, et al.
Publicado: (2004)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Transcriptional response to hypoxia of normal and rheumatoid arthritis synovial fibroblasts
por: Del Rey, M J, et al.
Publicado: (2010)

Functional Toll-like receptor 9 modulates the activity of bone marrow B cells isolated from rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2005)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

Caspase-1 is active since the early phase of rheumatoid arthritis
por: Cascão, R, et al.
Publicado: (2010)

Extrathymic Autoimmune Regulator (AIRE) expression in rheumatoid arthritis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_52s1rlp0ng21gi8993oqejvq6f